Exjade 125 mg
Exjade 125 mg is a medicine authorised by Swissmedic under authorisation number 57466. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 November 2005 and the authorisation is valid without a time limit. ATC code V03AC03 places the medicine in the group All other therapeutic products.
| Authorisation number | 57466 |
|---|---|
| Name | Exjade 125 mg |
| Full name | Exjade 125 mg, dispergierbare Tabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V03AC03 |
| First authorisation | 03 November 2005 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Exjade 125 mg, dispergierbare Tabletten | B | 03 November 2005 |
| 2 | Exjade 250 mg, dispergierbare Tabletten | B | 03 November 2005 |
| 3 | Exjade 500 mg, dispergierbare Tabletten | B | 03 November 2005 |
| 4 | Exjade 400 mg, dispergierbare Tabletten | B | 04 May 2007 |
| 5 | Exjade 100 mg, dispergierbare Tabletten | B | 19 October 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | V03AC03 | 06.99.0. | B |
| 3 | 84 | Tablette(n) | V03AC03 | 06.99.0. | B |
| 5 | 28 | Tablette(n) | V03AC03 | 06.99.0. | B |
| 7 | 84 | Tablette(n) | V03AC03 | 06.99.0. | B |
| 9 | 28 | Tablette(n) | V03AC03 | 06.99.0. | B |
| 11 | 84 | Tablette(n) | V03AC03 | 06.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Exjade 125 mg authorised in Switzerland?
Yes. Exjade 125 mg is authorised by Swissmedic under authorisation number 57466, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Exjade 125 mg have?
Exjade 125 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Exjade 125 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.